...
首页> 外文期刊>Free radical research >Targeting superoxide dismutase to renal proximal tubule cells attenuates vancomycin-induced nephrotoxicity in rats.
【24h】

Targeting superoxide dismutase to renal proximal tubule cells attenuates vancomycin-induced nephrotoxicity in rats.

机译:将超氧化物歧化酶靶向肾近端小管细胞可减弱万古霉素诱导的大鼠肾毒性。

获取原文
获取原文并翻译 | 示例
           

摘要

Vancomycin hydrochloride (VCM), a glycopeptide antibiotic, has a broad spectrum against methicillin-resistant Staphylococcus aureus (MRSA). As it is known to induce renal dysfunction, the dose and the duration of its administration are limited. Moreover, the mechanism of VCM-induced renal dysfunction remains to be unclear. To evaluate the involvement of free radical on VCM-induced renal dysfunction, we carried out analysis with a hexamethylenediamine-conjugated superoxide dismutase (AH-SOD) which rapidly accumulates in renal proximal tubule cells and inhibits oxidative injury of the kidney. Male Wistar rats (weighing 200-210 g) were intraperitonealy administered with 200 mg/kg of VCM twice a day for 7 days. AH-SOD 5 mg/kg/day was subcutaneously injected 5 min before every VCM injection. VCM induced renal injury dose-dependently. Biochemical analyses revealed that plasma levels of blood urea nitrogen and creatinine significantly increased in the VCM-treated group by an AH-SOD-inhibitable mechanism. VCM simultaneously elicited an increase of 8-OHdG levels and chemiluminescence intensity of free radical generation in the kidney. Histological examination revealed that VCM also elicited a marked destruction of glomeruli and necrosis of proximal tubules. AH-SOD inhibited these phenomena in the kidney. These results suggested that oxidative stress might underlie the pathogenesis of VCM-induced nephrotoxicity and targeting SOD and/or related antioxidants to renal proximal tubules might permit the administration of higher doses of VCM sufficient for eradication of MRSA without causing renal injury.
机译:盐酸万古霉素(VCM)是一种糖肽抗生素,对耐甲氧西林的金黄色葡萄球菌(MRSA)具有广谱性。众所周知会诱发肾功能不全,因此给药的剂量和持续时间是有限的。此外,VCM引起的肾功能不全的机制尚不清楚。为了评估自由基对VCM诱导的肾功能不全的影响,我们用六亚甲基二胺结合的超氧化物歧化酶(AH-SOD)进行了分析,该酶迅速积累在肾近端小管细胞中并抑制肾脏的氧化损伤。每天两次向雄性Wistar大鼠(体重200-210 g)腹膜内给予200 mg / kg的VCM,共7天。每次VCM注射前5分钟,皮下注射AH-SOD 5 mg / kg /天。 VCM剂量依赖性地引起肾损伤。生化分析表明,通过AH-SOD抑制机制,VCM治疗组的血浆尿素氮和肌酐水平显着增加。 VCM同时引起肾脏中8 -OHdG水平的增加和自由基产生的化学发光强度。组织学检查显示,VCM还引起肾小球的明显破坏和近端小管坏死。 AH-SOD可抑制肾脏中的这些现象。这些结果表明,氧化应激可能是VCM引起的肾毒性的发病机理,而将SOD和/或相关抗氧化剂靶向肾近端小管可能允许给予更高剂量的VCM,足以根除MRSA而不会引起肾损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号